Singlet Oxygen in Photodynamic Therapy.

Pharmaceuticals (Basel)

MOE Key Laboratory of Medical Optoelectronics Science and Technology, Key Laboratory of Photonics Technology of Fujian Province, School of Optoelectronics and Information Engineering, Fujian Normal University, Fuzhou 350117, China.

Published: September 2024

Photodynamic therapy (PDT) is a therapeutic modality that depends on the interaction of light, photosensitizers, and oxygen. The photon absorption and energy transfer process can lead to the Type II photochemical reaction of the photosensitizer and the production of singlet oxygen (O), which strongly oxidizes and reacts with biomolecules, ultimately causing oxidative damage to the target cells. Therefore, O is regarded as the key photocytotoxic species accountable for the initial photodynamic reactions for Type II photosensitizers. This article will provide a comprehensive review of O properties, O production, and O detection in the PDT process. The available O data of regulatory-approved photosensitizing drugs will also be discussed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11510636PMC
http://dx.doi.org/10.3390/ph17101274DOI Listing

Publication Analysis

Top Keywords

singlet oxygen
8
photodynamic therapy
8
oxygen photodynamic
4
therapy photodynamic
4
therapy pdt
4
pdt therapeutic
4
therapeutic modality
4
modality depends
4
depends interaction
4
interaction light
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!